Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Social Capital Suvretta Holdings Corp III Cl A (NQ: DNAC ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 11, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Social Capital Suvretta Holdings Corp III Cl A Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders July 08, 2022 From Social Capital Suvretta Holdings Corp. III Via Business Wire DNAC Stock: 11 Things to Know Ahead of the ProKidney SPAC Merger March 01, 2022 Palihapitiya's SPAC with ProKidney is expected to close during Q3 of this year. Here's what you need to know about the biotech company. Via InvestorPlace 7 Worst SPACs for Smart Investors to Skip in 2022 January 26, 2022 SPACs may make a comeback in 2022. But some of them won't ever recover. These 7 SPACs have a challenging future ahead of themselves. Via InvestorPlace ProKidney Turns To Palihapitiya-Backed SPAC To Go Public In $2.6B Deal January 18, 2022 ProKidney LP agreed to become a publicly-traded company via a business combination with Chamath Palihapitiya-backed special purpose acquisition company Social Capital... Via Benzinga SOFI Stock: 11 Reasons Why Investors Are Banking On a SoFi Bank Charter January 18, 2022 SoFi Technologies (SOFI) stock is on the move Tuesday as investors discuss a bank charter for the company and what it could do to the stock. Via InvestorPlace What Roblox Bulls Are Saying as RBLX Stock Trends Today January 18, 2022 Roblox (RBLX) stock is on the rise Tuesday despite a lack of news from the gaming and game development platform but lots of chatter. Via InvestorPlace DNAC Stock Alert: Chamath Palihapitiya’s SPAC Preps for ProKidney Merger January 18, 2022 Investors are excited to hear that dealmaker Chamath Palihapitiya is proceeding with a new SPAC deal involving ProKidney. Via InvestorPlace Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III January 18, 2022 From Social Capital Suvretta Holdings Corp. III and ProKideny LP Via Business Wire 2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again? January 09, 2022 The 2022 year has started quietly for SPACs, with no deals announced in the first five trading days of the year. Although two new SPAC rumors have popped up since the market... Via Benzinga Stocks That Hit 52-Week Lows On Friday August 27, 2021 Before 10 a.m. ET on Friday, 29 stocks hit new 52-week lows. Significant Points: Campbell Soup (NYSE:CPB) was the biggest company by market cap to set a new 52-week low.... Via Benzinga Are Chamath Palihapitiya’s 4 New Biotech SPACs Worth a Look? July 06, 2021 In Chamath Palihapitiya's latest SPAC empire-building move, his four new new biotech SPACs in the genomics and biotech space are making waves. Via InvestorPlace Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering June 30, 2021 From Social Capital Suvretta Holdings Corp. III Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.